Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Chatterjee

Showing results (1071-1080 of 1,278) with videos related to

Pageof 128
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2018
Repurposing isoxazoline veterinary drugs for control of vector-borne human diseasesMarie Miglianico, Maarten Eldering, Hannah Slater, et al.
The Lancet. Infectious Diseases|June 3, 2026
Safety and immunogenicity of mRNA-based mpox vaccine candidate BNT166a: an open-label, dose-escalation, first-in-human trialFrank Bähner, Saul N Faust, Leela R L Davies, et al.
Molecular and Biochemical Parasitology|September 4, 2010
Identification of inhibitors for putative malaria drug targets among novel antimalarial compoundsGregory J Crowther, Alberto J Napuli, James H Gilligan, et al.
Antiviral Research|April 7, 2022
HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effectCaroline S Foo, Rana Abdelnabi, Suzanne J F Kaptein, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2013
Identification of a small molecule with activity against drug-resistant and persistent tuberculosisFeng Wang, Dhinakaran Sambandan, Rajkumar Halder, et al.
Cell Reports|March 30, 2021
Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replicationGustavo Garcia, Arun Sharma, Arunachalam Ramaiah, et al.
Journal of Medicinal Chemistry|April 25, 2012
Imidazolopiperazines: lead optimization of the second-generation antimalarial agentsAdvait Nagle, Tao Wu, Kelli Kuhen, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2013
KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitroAnne-Marie Zeeman, Sandra M van Amsterdam, Case W McNamara, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of tetrahydropyrazolopyrimidine carboxamide derivatives as potent and orally active antitubercular agentsFumiaki Yokokawa, Gang Wang, Wai Ling Chan, et al.
Science (New York, N.Y.)|August 22, 2020
Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimeticEmily N Chin, Chenguang Yu, Vincent F Vartabedian, et al.
Pageof 128

Showing results (1071-1080 of 1,278) with videos related to

Sort By:
Pageof 128
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2018
Repurposing isoxazoline veterinary drugs for control of vector-borne human diseasesMarie Miglianico, Maarten Eldering, Hannah Slater, et al.
The Lancet. Infectious Diseases|June 3, 2026
Safety and immunogenicity of mRNA-based mpox vaccine candidate BNT166a: an open-label, dose-escalation, first-in-human trialFrank Bähner, Saul N Faust, Leela R L Davies, et al.
Molecular and Biochemical Parasitology|September 4, 2010
Identification of inhibitors for putative malaria drug targets among novel antimalarial compoundsGregory J Crowther, Alberto J Napuli, James H Gilligan, et al.
Antiviral Research|April 7, 2022
HIV protease inhibitors Nelfinavir and Lopinavir/Ritonavir markedly improve lung pathology in SARS-CoV-2-infected Syrian hamsters despite lack of an antiviral effectCaroline S Foo, Rana Abdelnabi, Suzanne J F Kaptein, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2013
Identification of a small molecule with activity against drug-resistant and persistent tuberculosisFeng Wang, Dhinakaran Sambandan, Rajkumar Halder, et al.
Cell Reports|March 30, 2021
Antiviral drug screen identifies DNA-damage response inhibitor as potent blocker of SARS-CoV-2 replicationGustavo Garcia, Arun Sharma, Arunachalam Ramaiah, et al.
Journal of Medicinal Chemistry|April 25, 2012
Imidazolopiperazines: lead optimization of the second-generation antimalarial agentsAdvait Nagle, Tao Wu, Kelli Kuhen, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2013
KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitroAnne-Marie Zeeman, Sandra M van Amsterdam, Case W McNamara, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of tetrahydropyrazolopyrimidine carboxamide derivatives as potent and orally active antitubercular agentsFumiaki Yokokawa, Gang Wang, Wai Ling Chan, et al.
Science (New York, N.Y.)|August 22, 2020
Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimeticEmily N Chin, Chenguang Yu, Vincent F Vartabedian, et al.
Pageof 128